Albatha moves into mental health care

UAE-based Albatha Healthcare Group has taken a controlling stake in Insights Psychology, marking a decisive push into the country’s expanding mental health and behavioural services market.

The transaction brings Insights’ multidisciplinary clinical practice, its specialist staff and operational centres under Albatha’s healthcare umbrella. The group said the acquisition aligns with its strategy to broaden service lines beyond acute and chronic physical care into community-based mental health, where demand has been building across age groups.

Founded in Dubai, Insights operates specialist clinics providing direct patient care for neurodevelopmental and behavioural conditions, including attention deficit hyperactivity disorder and autism spectrum disorder. Its services include neurodevelopmental assessments, speech and language therapy, occupational therapy and psychotherapy, delivered by a team spanning clinical psychologists, therapists and allied health professionals. The practice has built a referral network with schools, paediatricians and family physicians, positioning it as a frontline provider for early diagnosis and ongoing intervention.

For Albatha, the deal offers immediate scale and expertise in a field that has historically been under-served. The group has been steadily expanding its healthcare portfolio, which already spans pharmaceuticals, medical devices, diagnostics and hospital services. Executives familiar with the transaction said mental health and behavioural care stood out as a segment where integrated delivery models could improve outcomes while meeting regulatory expectations around quality and continuity of care.

Boldly framed within the strategy, the expansion into mental health care reflects wider shifts in the UAE’s healthcare priorities. Policymakers and insurers have been encouraging earlier diagnosis and treatment of neurodevelopmental conditions, driven by demographic growth, increased awareness among families and educators, and the economic costs of untreated mental illness. Clinics specialising in autism and ADHD have reported longer waiting lists, particularly for assessments required by schools and employers.

Industry analysts note that consolidation is becoming more common as providers seek to combine clinical depth with operational resilience. Smaller practices often struggle with recruitment, compliance and technology investment, while larger groups can spread costs across networks and negotiate more effectively with insurers. Albatha’s acquisition of a controlling stake, rather than a minority holding, suggests an intent to integrate Insights into its broader systems while retaining the clinical autonomy that underpins patient trust.

Insights’ existing leadership and clinical teams are expected to remain in place, according to people briefed on the matter, with plans to expand capacity and add complementary services over time. The focus is likely to be on scaling assessments and therapy programmes, investing in digital tools for patient management, and widening geographic reach within the UAE. Any expansion would need to navigate licensing requirements and workforce constraints, particularly in specialised therapies where trained professionals are in short supply.

The move also mirrors a broader recalibration within Gulf healthcare markets, where mental health is increasingly viewed as essential infrastructure rather than a peripheral service. Employers are incorporating psychological support into benefits packages, schools are seeking formal assessments for learning support, and families are more willing to pursue early interventions. These trends have translated into steady growth for clinics offering evidence-based therapies, though pricing and insurance coverage remain sensitive issues.

For patients and families, the entry of a large healthcare group brings potential advantages and risks. Greater investment can shorten waiting times, standardise protocols and improve access to multidisciplinary teams. At the same time, advocates caution that commercial pressures must not dilute personalised care, particularly for children with complex needs who require long-term, coordinated support.